Edinburgh Research Explorer

Identification of STAC3 variants in non-Native American families with overlapping features of Carey-Fineman-Ziter syndrome and Moebius syndrome

Research output: Contribution to journalArticle

  • Aida Telegrafi
  • Bryn D Webb
  • Sarah M Robbins
  • Carlos E Speck-Martins
  • David FitzPatrick
  • Leah Fleming
  • Richard Redett
  • Andreas Dufke
  • Gunnar Houge
  • Jeske J T van Harssel
  • Alain Verloes
  • Angela Robles
  • Irini Manoli
  • Elizabeth C Engle
  • Ethylin W Jabs
  • David Valle
  • John Carey
  • Julie E Hoover-Fong
  • Nara L M Sobreira
  • Moebius Syndrome Research Consortium

Related Edinburgh Organisations

Open Access permissions



Original languageEnglish
JournalAmerican Journal of Medical Genetics Part A
Issue number10
Early online date4 Aug 2017
StatePublished - Oct 2017


Horstick et al. (2013) previously reported a homozygous p.Trp284Ser variant in STAC3 as the cause of Native American myopathy (NAM) in 5 Lumbee Native American families with congenital hypotonia and weakness, cleft palate, short stature, ptosis, kyphoscoliosis, talipes deformities, and susceptibility to malignant hyperthermia (MH). Here we present two non-Native American families, who were found to have STAC3 pathogenic variants. The first proband and her affected older sister are from a consanguineous Qatari family with a suspected clinical diagnosis of Carey-Fineman-Ziter syndrome (CFZS) based on features of hypotonia, myopathic facies with generalized weakness, ptosis, normal extraocular movements, cleft palate, growth delay, and kyphoscoliosis. We identified the homozygous c.851G>C;p.Trp284Ser variant in STAC3 in both sisters. The second proband and his affected sister are from a non-consanguineous, Puerto Rican family who was evaluated for a possible diagnosis of Moebius syndrome (MBS). His features included facial and generalized weakness, minimal limitation of horizontal gaze, cleft palate, and hypotonia, and he has a history of MH. The siblings were identified to be compound heterozygous for STAC3 variants c.851G>C;p.Trp284Ser and c.763_766delCTCT;p.Leu255IlefsX58. Given the phenotypic overlap of individuals with CFZS, MBS, and NAM, we screened STAC3 in 12 individuals diagnosed with CFZS and in 50 individuals diagnosed with MBS or a congenital facial weakness disorder. We did not identify any rare coding variants in STAC3. NAM should be considered in patients presenting with facial and generalized weakness, normal or mildly abnormal extraocular movement, hypotonia, cleft palate, and scoliosis, particularly if there is a history of MH.

    Research areas

  • Journal Article

ID: 43308342